associated with Pseudomonas infection, and inversely related to lung function [10] . Arginase is moreover thought to play a role in the pathogenesis of other lung diseases like asthma and chronic obstructive pulmonary diseases [11, 12] . Recently, inhaled L-arginine was demonstrated to be a safe and potentially beneficial treatment approach in CF [13] .
A possible mechanism to explain Sisson et al. 's [1] surprising finding of lower NO after VCPT may be an increase in arginase activity through oscillatory mechanical stimulation of lung epithelial cells. Several studies in animal and cell models have demonstrated that specific patterns of mechanical stimulation can induce vascular endothelial arginase expression and activity. For instance, oscillatory shear stress induced stronger arginase activation than application of unidirectional shear force in porcine [14] and ApoE-deficient murine carotid artery segments [15] . An in vitro study showed that cyclic stretching of vascular smooth muscle cells upregulated arginase mRNA expression and enzyme activity whilst inhibiting NOS [16] 
